Study of Remote Fetal Monitoring in Pregnancy (The SHOW-ME Study)
This study is looking at how well a remote fetal monitoring system, called INVU, works for pregnant individuals who need weekly non-stress tests (a common test to check on your baby's health). Instead of going to a clinic, you would use the INVU system at home with its app. Researchers want to understand if using INVU improves satisfaction for both patients and healthcare providers, and if it saves money compared to in-person testing. You may be able to join if you are over 18, speak English, are pregnant with one baby, and need antenatal testing between 32 and 40 weeks of pregnancy, with certain medical conditions like gestational diabetes. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study planning to enroll 150 women. It will evaluate the implementation of a remote fetal-monitoring system.
- What's involved
- You will be recruited at any time during pregnancy if you meet inclusion criteria and require antenatal fetal testing between 32 and 40 weeks gestation. You will use the INVU fetal monitoring system at home.
- Compensation
- If you have Missouri Medicaid, your expenses will be covered by the study. If you have private insurance or are self-pay, you will need to pay all expenses out of pocket.
- Follow-up
- The primary endpoint is measured at the time participants are recruited during pregnancy if they require antenatal fetal testing between 32 and 40 weeks gestation.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Study of Fetal Health Outcomes: Working With a Missouri E-telehealth Platform (The SHOW-ME Study)
At a glance
Conditions
Where it's being run
3 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Evaluate the implementation of a remote fetal-monitoring system through RE-AIM quest frameworkParticipants will be recruited at any time during pregnancy if they meet inclusion criteria and require antenatal fetal testing between 32 and 40 weeks gestation
Each of the three participating centers and patients will receive access to and training in the INVU telehealth platform with the goal of studying the implementation (through pre and post implementation questionnaires) of this novel telehealth system and its impact on both patients and providers